Previous Speakers | Kisaco Research

Previous Speakers

Advanced Wound Care EU
November 2024
London, UK
  • Author:

    Isabel Henkel

    Global Director Market Access
    Essity

    Isabel Henkel

    Global Director Market Access
    Essity
  • Author:

    Monique Rennie

    Global Director, Medical Affairs
    Mölnlycke

    Monique Rennie

    Global Director, Medical Affairs
    Mölnlycke
  • Author:

    Asif Shahinsha

    Senior Director
    PharmaVentures

    Asif Shahinsha

    Senior Director
    PharmaVentures
  • Author:

    Mitch Sanders

    Chief Executive Officer
    ProDevLabs

    Mitch Sanders

    Chief Executive Officer
    ProDevLabs
  • Author:

    James McHale

    Global Value-Based Partnership Manager
    Mölnlycke

    James McHale

    Global Value-Based Partnership Manager
    Mölnlycke
  • Author:

    Janette Thomas

    Co-founder and Chief Executive Officer
    Pellis Care

    Janette Thomas

    Co-founder and Chief Executive Officer
    Pellis Care
  • Author:

    Pierre Socha

    Partner
    Amadeus Capital Partners

    Pierre Socha

    Partner
    Amadeus Capital Partners
  • Author:

    Mary McGovern

    Managing Director
    Adtec Healthcare Limited

    Mary McGovern

    Managing Director
    Adtec Healthcare Limited
  • Author:

    Daphne Hazell

    Chief Executive Officer
    Home Wound Care

    Daphne Hazell

    Chief Executive Officer
    Home Wound Care
  • Author:

    Meelis Kadaja

    Co-Founder & Chief Business Officer
    Nanordica Medical

    Meelis Kadaja

    Co-Founder & Chief Business Officer
    Nanordica Medical
  • Author:

    Jens Kirsch

    CEO
    Terraplasma Medical

    Jens Kirsch

    CEO
    Terraplasma Medical
  • Author:

    Alberto Ramos

    Chief Scientific Officer
    Untech

    Alberto Ramos

    Chief Scientific Officer
    Untech
  • Author:

    Thomas Serena

    Founder & CEO
    SerenaGroup

    Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

    To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.

    He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.

    Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.

    Thomas Serena

    Founder & CEO
    SerenaGroup

    Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

    To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.

    He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.

    Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.

  • Author:

    Martin Funk

    Chief Executive Officer
    Evomedis

    Martin Funk

    Chief Executive Officer
    Evomedis
  • Author:

    Laurent Decory

    COO
    Aurealis Therapeutics

    Laurent Decory

    COO
    Aurealis Therapeutics
  • Author:

    Gadi Borkow

    Chief Technology Officer and Co-Founder
    MedCu Technologies

    Gadi Borkow

    Chief Technology Officer and Co-Founder
    MedCu Technologies
  • Author:

    Thariea Whisker

    Director of Minuteful for Wound Services UK
    Healthy.io

    Thariea Whisker

    Director of Minuteful for Wound Services UK
    Healthy.io
  • Author:

    Mike Griffiths

    Chief Executive Officer & Medical Director
    Advanced Oxygen Therapy

    Mike Griffiths

    Chief Executive Officer & Medical Director
    Advanced Oxygen Therapy
  • Author:

    Lennart Stradler

    General Manager & Senior Analyst, Wound
    SMARTTRAK

    Lennart Stradler

    General Manager & Senior Analyst, Wound
    SMARTTRAK
  • Author:

    Carsten Mahrenholz

    Founder & Chief Executive Officer
    Coldplasmatech

    Carsten Mahrenholz

    Founder & Chief Executive Officer
    Coldplasmatech
  • Author:

    David Pérez Barreno

    President
    Spanish Vascular Nursing Wound Association

    David Pérez Barreno

    President
    Spanish Vascular Nursing Wound Association
  • Author:

    Thierry Sarda

    Chief Executive Officer
    Vistacare

    Thierry Sarda

    Chief Executive Officer
    Vistacare
  • Author:

    Anthony Kerr

    Managing Director
    Journal of Wound Care

    Anthony Kerr

    Managing Director
    Journal of Wound Care
  • Author:

    Barry Wolfenson

    Executive Vice President, Corporate Development & Strategy
    MediWound

    Barry Wolfenson

    Executive Vice President, Corporate Development & Strategy
    MediWound
  • Author:

    Jeiram Jeyaratnam

    Business Development Manager
    Adtec Healthcare

    Jeiram Jeyaratnam

    Business Development Manager
    Adtec Healthcare
  • Author:

    Tracy Cowen

    Associate Publisher, Medical Education
    Mark Allen Group

    Tracy Cowen

    Associate Publisher, Medical Education
    Mark Allen Group
  • Author:

    Gabor Heltovics

    Venture Partner
    NLC Venture Builder

    Gabor Heltovics

    Venture Partner
    NLC Venture Builder
  • Author:

    David Fairlamb

    Head of Regulatory Affairs
    Solascure

    David Fairlamb

    Head of Regulatory Affairs
    Solascure
  • Author:

    Marc Thurner

    Chief Executive Officer & Founder
    MimiX Biotherapeutics

    Marc Thurner

    Chief Executive Officer & Founder
    MimiX Biotherapeutics
  • Author:

    Paul Murphy

    Director
    Impact Healthcare Consulting

    Paul Murphy

    Director
    Impact Healthcare Consulting